Epicardial Adipose Tissue in Arrhythmogenic Cardiomyopathy

Davide Lapolla1, Luca Canovi1, Maria Letizia Berloni1

  • 1Cardiology Unit, Azienda Ospedaliero Universitaria of Ferrara, 44124 FE, Italy.

Biology
|March 26, 2025
PubMed

Insights

Arrhythmogenic cardiomyopathy (ACM) patients show increased epicardial adipose tissue (EAT). This EAT amount appears to correlate with disease progression, suggesting a role in ACM pathogenesis.

Area of Science:

  • Cardiology
  • Genetics
  • Medical Imaging

Background:

  • Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiac condition marked by fibrofatty myocardial replacement.
  • Sudden cardiac death is a primary presentation in 16-23% of ACM patients.
  • Epicardial fat's role in cardiac disease is increasingly recognized, yet its specific involvement in ACM remains under-explored.

Purpose of the Study:

  • To investigate epicardial adipose tissue (EAT) volume in patients with arrhythmogenic cardiomyopathy.
  • To determine if EAT volume differs between ACM patients and healthy controls.
  • To explore the relationship between EAT volume and ACM disease progression.

Main Methods:

  • Cardiac magnetic resonance (CMR) imaging was utilized to quantify EAT volume.
  • ACM patients and a control group were included in the study.
  • Statistical analyses were performed to compare EAT volumes and assess correlations.

Main Results:

  • Patients with ACM exhibited significantly higher EAT volumes compared to control subjects.
  • A positive correlation was observed between EAT volume and the clinical progression of ACM.
  • Fibrofatty infiltration, a hallmark of ACM, was assessed via CMR.

Conclusions:

  • Elevated epicardial adipose tissue is a characteristic feature of arrhythmogenic cardiomyopathy.
  • Increased EAT may play a pathogenic role in ACM and its progression.
  • CMR is a valuable tool for assessing both myocardial and epicardial fat in ACM.